tradingkey.logo
tradingkey.logo
Search

Anbio Biotechnology

NNNN
Add to Watchlist
12.700USD
+0.355+2.88%
Close 07/02, 13:00ETQuotes delayed by 15 min
557.42MMarket Cap
86.61P/E TTM

More Details of Anbio Biotechnology Company

Anbio Biotechnology is a Germany-based medical device company. The Company is engaged in the development of medical technology and the provision of in vitro diagnostics (IVD) products. Its products offer solutions for over the counter (OTC) use, point-of-care (POCT) settings, and laboratory applications, ensuring that both healthcare providers and patients have access to reliable and efficient diagnostic tools in any setting. Its IVD products detect a wide range of biomarkers across critical medical fields, including infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Some of its IVD platforms: Chemiluminescence Immunoassay (ChLIA), Lateral Flow Immunoassay (LFIA), Fluorescent Immunoassay (FIA), Polymerase Chain Reaction (PCR) and Loop-mediated Isothermal Amplification (LAMP).

Anbio Biotechnology Info

Ticker SymbolNNNN
Company nameAnbio Biotechnology
IPO dateFeb 19, 2025
CEOLau (Michael)
Number of employees27
Security typeOrdinary Share
Fiscal year-endFeb 19
AddressFriedrich-Ebert-Anlage 49
CityFRANKFURT AM MAIN
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryGermany
Postal code60308
Phone4916096247281
Websitehttps://anbiobiotechnology.com/
Ticker SymbolNNNN
IPO dateFeb 19, 2025
CEOLau (Michael)

Company Executives of Anbio Biotechnology

Name
Name/Position
Position
Shareholding
Change
Mr. Michael Lau
Mr. Michael Lau
Chief Executive Officer
Chief Executive Officer
--
--
Ms. Suki Song
Ms. Suki Song
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Chris Tiantian
Mr. Chris Tiantian
Chief Business Officer
Chief Business Officer
--
--
Mr. Cany Xu
Mr. Cany Xu
Executive Director
Executive Director
--
--
Ms. Nancy Hartzler
Ms. Nancy Hartzler
Independent Director
Independent Director
--
--
Mr. Kenneth Li
Mr. Kenneth Li
Independent Director
Independent Director
--
--
Mr. David Hsu
Mr. David Hsu
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Michael Lau
Mr. Michael Lau
Chief Executive Officer
Chief Executive Officer
--
--
Ms. Suki Song
Ms. Suki Song
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Chris Tiantian
Mr. Chris Tiantian
Chief Business Officer
Chief Business Officer
--
--
Mr. Cany Xu
Mr. Cany Xu
Executive Director
Executive Director
--
--
Ms. Nancy Hartzler
Ms. Nancy Hartzler
Independent Director
Independent Director
--
--
Mr. Kenneth Li
Mr. Kenneth Li
Independent Director
Independent Director
--
--

FAQs

Who are the top five shareholders of Anbio Biotechnology?

The top five shareholders of Anbio Biotechnology are: Mr. Michael Lau

How many institutions hold shares of Anbio Biotechnology (NNNN)?

As of 2026Q1, 13 institutions hold shares of Anbio Biotechnology, with a combined market value of approximately 2.13M, accounting for 4.86% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 2063041.00.